NYSE:TEVAPharmaceuticals
Is Teva Pharmaceutical Industries (TEVA) Still Attractive After A 92% One-Year Share Price Surge
If you are wondering whether Teva Pharmaceutical Industries is priced for further gains or already reflecting most of the good news, starting with a clear look at its current valuation can help you frame that question.
Teva’s share price closed at US$34.08, with returns of 7.1% over 7 days, 9.2% over 30 days, 10.1% year to date, 92.2% over 1 year, 216.7% over 3 years and 178.4% over 5 years. This naturally raises questions about what is already built into the price and what might still be on...